Skip to main content
. Author manuscript; available in PMC: 2009 Aug 17.
Published in final edited form as: Neurobiol Aging. 2006 Dec 26;29(4):566–573. doi: 10.1016/j.neurobiolaging.2006.10.032

Table 3.

A Comparison of subjects with AG with and without dementia

AG with dementia (N=8) AG without dementia (N=14) P value
Female gender 4 (50%) 10 (71%) ns
*Age at onset of dementia 87 years (73–97) n/a n/a
*MMSE score prior to death 20.5 (5–28) 28 (22–30) 0.002
*Age at death 90.5 years (77–100) 89.5 years (74–101) ns
*Braak stage 4 (3–4) 3 (0–4) 0.02
Number of subjects with Braak stage ≤ 2 0 (0%) 5 (36%) ns
Number of subjects that fulfilled Khachaturian criteria 5 (63%) 8 (57%) ns
Number of subjects that fulfilled CERAD criteria - C 0 (0%) 0 (0%) ns
Number of subjects that fulfilled CERAD criteria – B 2 (25%) 0 (0%) ns
Number of subjects that fulfilled CERAD criteria - A 5 (63%) 5 (38%) ns
βNumber of subjects that fulfilled CERAD criteria - 0 1 (13%) 9 (64%) 0.03
Number of subjects that fulfilled NIA-Reagan criteria for AD 0 (0%) 0 (0%) ns

ns = not significant, n/a = not applicable; MMSE = Mini-mental State Examination

*

Values shown are medians (range)

β

Not significant after adjusting for multiple comparisons

HHS Vulnerability Disclosure